山东药玻(600529) - 2016 Q4 - 年度财报(更正)

Key Management Personnel Remuneration - Key management personnel remuneration for the current period is ¥8,007,659.88, an increase from ¥3,277,022.64 in the previous period[2] - The unit for key management personnel remuneration was corrected from "万元" to "元" due to a clerical error[2] - The company expresses apologies for any inconvenience caused to investors due to the correction[2] - The financial report remains unchanged aside from the correction of the remuneration unit[2] - The announcement was made by the board of directors on April 25, 2017[4]